Postoperative standard chemoradiotherapy benefits primary glioblastoma patients of all ages-Reference-Cited by-同舟云学术

Postoperative standard chemoradiotherapy benefits primary glioblastoma patients of all ages

Published:2019-12-18 Issue:6 Volume:9 Page:1955-1965
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Li Guanzhang¹,Zhai You¹,Wang Zheng²,Wang Zhiliang¹,Huang Ruoyu¹,Jiang Haoyu²,Li Renpeng²,Feng Yuemei¹,Chang Yuanhao¹,Jiang Tao¹²³⁴⁵^ORCID,Zhang Wei²⁵^ORCID

Affiliation:

1. Department of Molecular Neuropathology Beijing Neurosurgical Institute Capital Medical University Beijing China

2. Department of Neurosurgery Beijing Tiantan Hospital Capital Medical University Beijing China

3. Center of Brain Tumor Beijing Institute for Brain Disorders Beijing China

4. China National Clinical Research Center for Neurological Diseases Beijing China

5. Chinese Glioma Genome Atlas Network (CGGA) and Asian Glioma Genome Atlas Network (AGGA) Beijing China

Funder

National Natural Science Foundation of China

Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.2754

Reference23 articles.

1. CGCG clinical practice guidelines for the management of adult diffuse gliomas

2. The epidemiology of glioma in adults: a "state of the science" review

3. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

4. Identification of high risk anaplastic gliomas by a diagnostic and prognostic signature derived from mRNA expression profiling

5. MGMTGene Silencing and Benefit from Temozolomide in Glioblastoma

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification and validation of a glycolysis‐related taxonomy for improving outcomes in glioma;CNS Neuroscience & Therapeutics;2024-02

2. IQGAP3 promotes the progression of glioma as an immune and prognostic marker;Oncology Research;2024

3. TCAF2 drives glioma cellular migratory/invasion properties through STAT3 signaling;Molecular and Cellular Biochemistry;2023-11-29

4. Predictive models and survival analysis of postoperative mental health disturbances in adult glioma patients;Frontiers in Oncology;2023-04-21

5. CDC6 is a prognostic biomarker and correlated with immune infiltrates in glioma;Molecular Cancer;2022-07-25